Amphastar Pharmaceuticals Receivables 2012-2024 | AMPH

Amphastar Pharmaceuticals receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company
Amphastar Pharmaceuticals Annual Receivables
(Millions of US $)
2023 $115
2022 $89
2021 $79
2020 $66
2019 $46
2018 $52
2017 $42
2016 $27
2015 $33
2014 $23
2013 $27
2012 $38
2011 $
2009 $25
Amphastar Pharmaceuticals Quarterly Receivables
(Millions of US $)
2024-09-30 $145
2024-06-30 $132
2024-03-31 $139
2023-12-31 $115
2023-09-30 $120
2023-06-30 $106
2023-03-31 $101
2022-12-31 $89
2022-09-30 $88
2022-06-30 $87
2022-03-31 $73
2021-12-31 $79
2021-09-30 $79
2021-06-30 $69
2021-03-31 $79
2020-12-31 $66
2020-09-30 $54
2020-06-30 $51
2020-03-31 $59
2019-12-31 $46
2019-09-30 $46
2019-06-30 $49
2019-03-31 $57
2018-12-31 $52
2018-09-30 $47
2018-06-30 $49
2018-03-31 $44
2017-12-31 $42
2017-09-30 $25
2017-06-30 $25
2017-03-31 $26
2016-12-31 $27
2016-09-30 $27
2016-06-30 $23
2016-03-31 $23
2015-12-31 $33
2015-09-30 $31
2015-06-30 $26
2015-03-31 $24
2014-12-31 $23
2014-09-30 $32
2014-06-30 $23
2014-03-31 $22
2013-12-31 $27
2013-09-30
2013-06-30
2013-03-31
2012-12-31 $38
2012-09-30
2012-06-30
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.335B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.679B 6.46
Dr Reddy's Laboratories (RDY) India $12.521B 23.96
BridgeBio Pharma (BBIO) United States $4.911B 0.00
Bausch Health Cos (BHC) Canada $3.439B 2.49
Supernus Pharmaceuticals (SUPN) United States $2.022B 27.53
Taysha Gene Therapies (TSHA) United States $0.334B 54.33
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00